Abstract
AbstractGrowth hormone (GH) is a key modulator of growth and GH over-secretion can lead to gigantism. One form is X-linked acrogigantism (X-LAG), in which infants develop GH-secreting pituitary tumors over-expressing the orphan G-protein coupled receptor, GPR101. The role of GPR101 in GH secretion remains obscure. We studied GPR101 signaling pathways and their effects in HEK293 and rat pituitary GH3 cell lines, human tumors and in transgenic mice with elevated somatotrope Gpr101 expression driven by the rat Ghrhr promoter (GhrhrGpr101). Here, we report that Gpr101 causes elevated GH/prolactin secretion in transgenic GhrhrGpr101 mice but without hyperplasia/tumorigenesis. We show that GPR101 constitutively activates not only Gs, but also Gq/11 and G12/13, which leads to GH secretion but not proliferation. These signatures of GPR101 signaling, notably PKC activation, are also present in human pituitary tumors with high GPR101 expression. These results underline a role for GPR101 in the regulation of somatotrope axis function.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference64 articles.
1. Lui, J. C., Garrison, P. & Baron, J. Regulation of body growth. Curr. Opin. Pediatr. 27, 502–510 (2015).
2. Buchman, M., Bell, S. & Kopchick, J. J. Growth hormone discovery and structure. Pediatr. Endocrinol. Rev. 16, 2–10 (2018).
3. Steyn, F. J., Tolle, V., Chen, C. & Epelbaum, J. In Comprehensive Physiology vol. 6, pp. 687–735 (John Wiley & Sons, Inc., 2016).
4. Beckers, A., Petrossians, P., Hanson, J. & Daly, A. F. The causes and consequences of pituitary gigantism. Nat. Rev. Endocrinol. 14, 705–720 (2018).
5. Rostomyan, L. et al. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr. Relat. Cancer 22, 745–757 (2015).
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献